RxDoctor Payments Data

Ray Lara, DO

Otolaryngology/Facial Plastic Surgery · Oro Valley, AZNPI 1750583951

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations.

$4,450in general payments, 2019–2025

Across 108 payments — averaging $41.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$981
  • GSK$454
  • Sanofi$407
  • Aerin Medical Inc.$380
  • Medtronic$367
  • Acclarent, Inc$243
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$1213%
  • Food & beverage$4,29597%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$538,126
Medicare patients
1,454
Services billed
5,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide578$18,864
Azelastine Hcl504$17,153
Fluticasone Propionate514$8,344
Montelukast Sodium483$4,876
Methylprednisolone416$2,835
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth16$2,090
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort34$1,807
Fluocinolone Acetonide Oil19$951
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav87$898
Mupirocin71$896
Ofloxacin32$881
Triamcinolone Acetonide23$824
Famotidine21$643
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc72$484
Levocetirizine Dihydrochloride28$328

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Oro Valley

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →